Atlas Trials

A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease

Clinical trial NCT04867642 · COMPLETED

Trial details

NCT number
NCT04867642
Sponsor
UCB Biopharma SRL
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Study ParticipantsParkinson's Disease
Start date
2021-04-29
Primary completion
2023-02-27
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.